valproic acid has been researched along with oxamflatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, C; Mizutani, E; Ono, T; Terashita, Y; Wakayama, T; Yamagata, K | 1 |
Doyon, G; Fyne, E; Huber, K; Mellors, JW; Plaks, J; Sluis-Cremer, N | 1 |
2 other study(ies) available for valproic acid and oxamflatin
Article | Year |
---|---|
Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice.
Topics: Animals; Apoptosis; Cell Line; Cellular Reprogramming; Cloning, Organism; Embryonic Development; Female; Fetal Development; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Hydroxamic Acids; Isoenzymes; Male; Mice; Mice, Transgenic; Nuclear Transfer Techniques; Oocytes; Pluripotent Stem Cells; Valproic Acid; Vorinostat | 2010 |
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Topics: Adult; Histone Deacetylase Inhibitors; Histone Deacetylases; HIV Long Terminal Repeat; HIV-1; Humans; Hydroxamic Acids; Jurkat Cells; Peptides, Cyclic; Phosphatidylinositol 3-Kinases; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; Substrate Specificity; Valproic Acid; Virus Activation; Virus Latency | 2011 |